MaxCyte (NASDAQ:MXCT – Get Free Report) will likely be posting its quarterly earnings results after the market closes on Tuesday, March 11th. Analysts expect MaxCyte to post earnings of ($0.14) per share and revenue of $7.98 million for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.
MaxCyte Price Performance
MaxCyte stock opened at $3.51 on Friday. The firm has a 50 day simple moving average of $4.26 and a 200-day simple moving average of $4.00. The stock has a market capitalization of $371.92 million, a PE ratio of -10.32 and a beta of 1.35. MaxCyte has a 12-month low of $3.16 and a 12-month high of $5.26.
MaxCyte Company Profile
Further Reading
- Five stocks we like better than MaxCyte
- Canada Bond Market Holiday: How to Invest and Trade
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- What Are Dividend Contenders? Investing in Dividend Contenders
- 3 Stocks to Buy While Others Stay on the Sidelines
- How to buy stock: A step-by-step guide for beginners
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.